News

Merck has secured European Union approval for a new perioperative treatment regimen combining KEYTRUDA (pembrolizumab) and Padcev (enfortumab vedotin-ejfv) for adults with resectable…
Read More...

Merck KGaA, Darmstadt, Germany, has announced a definitive agreement to acquire U.S.-based life sciences company Bio-Techne Corporation in an all-cash transaction valued at…
Read More...

Ionis Partners with Recordati to Commercialize Alexander Disease Therapy Outside U.S. Ionis Pharmaceuticals has entered into a strategic licensing agreement with Recordati to expand…
Read More...

Remix Therapeutics and Passage Bio have agreed to merge in an all-stock transaction, creating a combined biotechnology company focused on advancing RNA-targeted therapies for cancer and…
Read More...

ŌURA and LillyDirect have announced a new collaboration aimed at helping people using GLP-1 weight management medicines better manage their health through wearable technology and…
Read More...

Eli Lilly and Company has completed its acquisition of Centessa Pharmaceuticals plc, strengthening its neuroscience pipeline with promising therapies aimed at treating narcolepsy and…
Read More...

Bayer has entered into a strategic drug discovery collaboration with Iambic Therapeutics to accelerate the development of new small-molecule medicines using artificial intelligence. The…
Read More...

Lonza has entered into a new licensing agreement with biotechnology company InduPro to support the development of next-generation antibody-drug conjugate (ADC) therapies for cancer. The…
Read More...

Haisco Pharmaceutical Group has signed an exclusive licensing agreement with U.S.-based biotechnology company Nuvectis, granting the company rights to develop and commercialize two of…
Read More...

Combotope Therapeutics has entered into a strategic research collaboration with Boehringer Ingelheim to develop a new generation of tumor-selective antibody therapies for cancer. The…
Read More...

Abbisko Therapeutics has entered into a new strategic research collaboration and license agreement with Eli Lilly and Company to discover and develop innovative medicines across…
Read More...

Boehringer Ingelheim has announced the launch of three Phase III clinical trials aimed at advancing precision oncology for patients with some of the most aggressive forms of cancer. The…
Read More...

Voro Therapeutics and Alloy Therapeutics have entered into a strategic research collaboration aimed at developing a new generation of cancer immunotherapies designed to improve the…
Read More...

uniQure has reported encouraging early clinical results from its experimental gene therapy AMT-260, offering new hope for patients living with refractory mesial temporal lobe epilepsy…
Read More...

Boltz PBC, an applied artificial intelligence research company focused on biomolecular modeling, has announced a new collaboration with Takeda aimed at bringing advanced AI-driven tools…
Read More...

SK pharmteco has entered into a new strategic collaboration with the Orphan Therapeutics Accelerator (OTXL), a non-profit biotechnology organization focused on advancing stalled rare…
Read More...

Vedana Therapeutics has emerged from stealth mode with $46 million in Series A financing and ambitious plans to develop next-generation therapies for migraine prevention, targeting…
Read More...

LG AI Research and D&D Pharmatech have entered into a strategic partnership aimed at accelerating the development of next-generation oral peptide therapies, highlighting the growing…
Read More...

Jazz Pharmaceuticals and AbCellera have entered into a new research collaboration aimed at developing next-generation antibody-based treatments for gastrointestinal (GI) cancers and…
Read More...

Biogen has agreed to acquire private biotechnology company RayThera in a deal valued at up to $1 billion, strengthening the company's growing focus on immunology and expanding its…
Read More...